Crude Link ID’d for Vitamin D Levels, COVID-19 Cases, Death
Vitamin D levels severely low in aging population, the most vulnerable population to COVID-19
Anakinra May Reduce Systemic Inflammation in COVID-19
At 21 days, survival was 90 percent in anakinra group versus 56 percent in standard treatment group
Triple Antiviral Therapy Promising for Mild-to-Moderate COVID-19
Duration of viral shedding shorter with combination of lopinavir-ritonavir, ribavarin, interferon beta-1b
Residual Shunt After PFO Closure Linked to Higher Risk for Stroke
Risk for recurrent stroke, transient ischemic attack increased with presence of residual shunt
Hydroxychloroquine Has No Impact on Outcomes in COVID-19
No link seen between use of the drug and risk for composite end point of intubation or death
ACE Inhibitor/ARB Use Not Tied to COVID-19 Test Positivity
No significant association identified in overlap propensity score weighting analysis
Risk for SARS-CoV-2 Lower for Prostate Cancer Patients on ADT
Risk reduced fourfold with androgen-deprivation therapy versus other treatment for prostate cancer
Asthma, COPD Medication Adherence Up During Pandemic
Authors say increased adherence may reflect patient concern about controlling primary respiratory illness
CDC: Prevalence of Hypertension Higher in Rural Versus Urban Areas
HTN prevalence varied from 18.0 to 55.0 percent across counties; med use also higher in rural areas
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
